HORIBA Medical has developed the digital simulation activity within its Innovation & Development center for several years, relying on the COMSOL…

Yumizen G200 confirmed as suitable for blood coagulation external quality assessment testing

Two parties have signed a contract to meet the company’s requirements of biological samples for the validation and development of IVD solutions and…

HORIBA Medical has just purchased a 1 hectare plot next to its current site on the Euromédecine business park in Montpellier, with a view to expanding…

HORIBA Medical and LABORATORIO ECHEVARNE, one of the major Laboratory Medicine providers in Europe have signed a multi-year, multi-site contract for…

Based on innovative ‘data mining’ techniques and combined with Full Blood Count, the Malaria suspicion flag is optionally available on both the ABX…

HORIBA Medical announces the availability of a D-Dimer reagent for their semi-automated Hemostasis instruments.